6 results
Hydroxychloroquine - Risks and Benefits in Lupus
Benefits:
↓ Disease activity, ↓ Flare, ↓ Damage, ↓ Corticosteroid dose,
recommended with other medications ... caution] and G6PD deficiency ... of hemolysis], ... #pharmacology # ... #sideeffects #rheumatology
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Tranexamic Acid - Indications ... Post-partum, ICH/TBI, Hemoptysis ... fatigue; Increases risk ... Tranexamic #Acid #Indications ... hematology
Drug-induced Hemolysis in G6PD Deficiency
Medicines and other substances likely to be UNSAFE in moderate to severe
Drug-induced Hemolysis ... Medications: ... #DrugInduced #Hemolysis ... #Pharmacology # ... Diagnosis #Table #Medications
Medications to Avoid in Patients with G6PD Deficiency Due to Risk of Hemolysis
 - Chloroquine (Aralen)*
Medications to Avoid ... Due to Risk of ... #Hemolysis #Medications ... Differential #Diagnosis #Pharmacology ... #Hematology
Drug Induced Systemic Lupus Erythematosus
> 100 drugs have been associated with drug-induced SLE
High risk (>5%):
 •
Induced Systemic Lupus ... Lupusreference #DrugInduced ... Erythematosus #medications ... #drugs #pharmacology ... #diagnosis #rheumatology
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
Non-autoimmune rheumatologic ... disease • Prolidase deficiency ... Thrombosis highest risk ... activation and/or medications ... Erythematosus #Diagnosis #Rheumatology